Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Arterioscler Thromb Vasc Biol Retrieve available abstracts of 59 articles: HTML format

Single Articles

September 2025
1. GERDTS E, Novella S, Devaux Y, Magni P, et al
   Biological Sex and Cardiovascular Disease Prevention in Systemic Arterial Hypertension.
   Arterioscler Thromb Vasc Biol. 2025 Sep 11. doi: 10.1161/ATVBAHA.125.322092.
   PubMed     Abstract available
   
   
   
2. SANTINELLI-PESTANA DV, Delwarde C, Kasai T, Kuraoka S, et al
   ADP-Ribosylation in Experimental Atherosclerosis: A Potential Link Between Dyslipidemia and Inflammation in Cardiovascular Disease.
   Arterioscler Thromb Vasc Biol. 2025 Sep 4. doi: 10.1161/ATVBAHA.125.322497.
   PubMed    
   
   
   
3. GARSHICK MS, Drenkova K, Kazatsker F, Boothman I, et al
   Platelet Activation and a Platelet Biosignature Are Associated With Cardiovascular Risk in Patients With Controlled Psoriasis.
   Arterioscler Thromb Vasc Biol. 2025 Sep 4. doi: 10.1161/ATVBAHA.125.322574.
   PubMed     Abstract available
   
   
   
4. QIU B, Cai X, Zhou L, Wang X, et al
   Association of Serum Thromboinflammatory Biomarkers With Atherosclerotic Plaques and Burden in a Community-Based Population.
   Arterioscler Thromb Vasc Biol. 2025;45:1672-1682.
   PubMed     Abstract available
   
   
   August 2025
5. YARMOLINSKY J, Lau E, Koskeridis F, Gunter MJ, et al
   Genome-Wide Pleiotropy Analysis Identifies Shared and Opposing Pathways Influencing Coronary Artery Disease and Cancer.
   Arterioscler Thromb Vasc Biol. 2025 Aug 28. doi: 10.1161/ATVBAHA.125.322433.
   PubMed     Abstract available
   
   
   
6. TSIMIKAS S, Kille A, Kaier K, Nuhrenberg T, et al
   Oxidized Phospholipids on Apo B(100), Platelet Activation and Reactivity, and Long-Term Cardiovascular Outcomes.
   Arterioscler Thromb Vasc Biol. 2025 Aug 14. doi: 10.1161/ATVBAHA.125.322347.
   PubMed     Abstract available
   
   
   
7. ZUBIRAN R, Sampson M, Wolska A, Remaley AT, et al
   Estimated Small, Dense LDL Cholesterol and Atherosclerotic Cardiovascular Risk in the UK Biobank.
   Arterioscler Thromb Vasc Biol. 2025 Aug 14. doi: 10.1161/ATVBAHA.125.323157.
   PubMed     Abstract available
   
   
   
8. AL ZAIDI M, Nickenig G
   Circular RNAs Complement Cardiovascular Messaging Machinery.
   Arterioscler Thromb Vasc Biol. 2025 Aug 7. doi: 10.1161/ATVBAHA.125.323371.
   PubMed    
   
   
   July 2025
9. ANDERSEN T, Ueland T, Ghukasyan Lakic T, Akerblom A, et al
   Correction to: C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes.
   Arterioscler Thromb Vasc Biol. 2025;45:e336.
   PubMed    
   
   
   June 2025
10. HLUSHCHENKO I, Pamilo S, Islam MM, Lahdeniemi IAK, et al
    Linking Variability of Leukocyte Lipid Metabolism to Circulating Lipids, Lipoprotein Composition, and Cardiovascular Risk in the Finnish Adult Population.
    Arterioscler Thromb Vasc Biol. 2025 Jun 19. doi: 10.1161/ATVBAHA.125.322801.
    PubMed     Abstract available
    
    
    
11. RICCIOTTI E, FitzGerald GA
    Prostaglandins and the Cardiovascular System.
    Arterioscler Thromb Vasc Biol. 2025;45:841-844.
    PubMed    
    
    
    May 2025
12. NAGESWARAN V, Carreras A, Reinshagen L, Beck KR, et al
    Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2025;45:823-839.
    PubMed     Abstract available
    
    
    
13. BALINT L, Patel S, Serafin DS, Zhang H, et al
    Lymphatic Activation of ACKR3 Signaling Regulates Lymphatic Response After Ischemic Heart Injury.
    Arterioscler Thromb Vasc Biol. 2025;45:754-768.
    PubMed     Abstract available
    
    
    
14. MINUZ P, Giorgetti A, Meneguzzi A, Taus F, et al
    Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study.
    Arterioscler Thromb Vasc Biol. 2025;45:792-804.
    PubMed     Abstract available
    
    
    April 2025
15. JEON Y, Kwon Y, Kim YJ, Jeon S, et al
    Epigenetic Modulation of Vascular Smooth Muscle Cell Phenotype Switching in Early-Onset Acute Myocardial Infarction.
    Arterioscler Thromb Vasc Biol. 2025 Apr 17. doi: 10.1161/ATVBAHA.125.322503.
    PubMed     Abstract available
    
    
    
16. SANGHVI MM, Young WJ, Naderi H, Burns R, et al
    Using Genomics to Develop Personalized Cardiovascular Treatments.
    Arterioscler Thromb Vasc Biol. 2025 Apr 17. doi: 10.1161/ATVBAHA.125.319221.
    PubMed     Abstract available
    
    
    March 2025
17. SALIDO E, de Medeiros Vieira C, Mosquera JV, Zade R, et al
    9p21.3 Coronary Artery Disease Risk Locus Drives Vascular Smooth Muscle Cells to an Osteochondrogenic State.
    Arterioscler Thromb Vasc Biol. 2025 Mar 27. doi: 10.1161/ATVBAHA.124.322045.
    PubMed     Abstract available
    
    
    
18. STADLER JT, Borenich A, Stattau Bisgaard L, Bjergfelt SS, et al
    ApoM and Major Adverse Cardiovascular Events in Chronic Kidney Disease: A Prospective Cohort Study.
    Arterioscler Thromb Vasc Biol. 2025 Mar 6. doi: 10.1161/ATVBAHA.124.322367.
    PubMed     Abstract available
    
    
    
19. LEANDER K, Chen YQ, Vikstrom M, Silveira A, et al
    Circulating ANGPTL3/8 Concentrations Are Associated With an Atherogenic Lipoprotein Profile and Increased CHD Risk in Swedish Population-Based Studies.
    Arterioscler Thromb Vasc Biol. 2025;45:443-451.
    PubMed     Abstract available
    
    
    
20. 
    Correction to: Effect of Vectors on Human Endothelial Cell Signal Transduction: Implications for Cardiovascular Gene Therapy.
    Arterioscler Thromb Vasc Biol. 2025;45:e99.
    PubMed    
    
    
    
21. 
    Correction to: Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks-Brief Report.
    Arterioscler Thromb Vasc Biol. 2025;45:e100.
    PubMed    
    
    
    January 2025
22. NEWMAN AAC, Dalman JM, Moore KJ
    Cardiovascular Disease and Cancer: A Dangerous Liaison.
    Arterioscler Thromb Vasc Biol. 2025 Jan 9. doi: 10.1161/ATVBAHA.124.319863.
    PubMed     Abstract available
    
    
    December 2024
23. STONE CR, Harris DD, Broadwin M, Kanuparthy M, et al
    Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2024 Dec 12. doi: 10.1161/ATVBAHA.124.321850.
    PubMed     Abstract available
    
    
    
24. JI H, Sabanayagam C, Matsushita K, Cheng CY, et al
    Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks.
    Arterioscler Thromb Vasc Biol. 2024 Dec 12. doi: 10.1161/ATVBAHA.124.321629.
    PubMed     Abstract available
    
    
    
25. LIOU L, Garcia-Gonzalez J, Wu HM, Wang Z, et al
    Clinical and Genomic Prediction of Coronary Artery Disease Subtypes.
    Arterioscler Thromb Vasc Biol. 2024 Dec 5. doi: 10.1161/ATVBAHA.124.321846.
    PubMed     Abstract available
    
    
    
26. VAN ECK M
    SR-BI Models for Spontaneous Myocardial Infarction: High Unesterified/Total Cholesterol Ratio Not the Sole Piece of the Puzzle.
    Arterioscler Thromb Vasc Biol. 2024;44:2489-2492.
    PubMed    
    
    
    
27. GAO XF, Chen AQ, Tang HY, Kong XQ, et al
    m(6)A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway.
    Arterioscler Thromb Vasc Biol. 2024;44:2543-2559.
    PubMed     Abstract available
    
    
    
28. BAATEN CCFMJ, Nagy M, Spronk HMH, Ten Cate H, et al
    NETosis in Cardiovascular Disease: An Opportunity for Personalized Antithrombotic Treatments?
    Arterioscler Thromb Vasc Biol. 2024;44:2366-2370.
    PubMed    
    
    
    November 2024
29. KHRAISHAH H, Ostergard RL Jr, Nabi SR, De Alwis D, et al
    Climate Change and Cardiovascular Disease: Who Is Vulnerable?
    Arterioscler Thromb Vasc Biol. 2024 Nov 26. doi: 10.1161/ATVBAHA.124.318681.
    PubMed     Abstract available
    
    
    
30. BONDONNO NP, Parmenter BH, Murray K, Bondonno CP, et al
    Associations Between Flavonoid Intake and Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2024;44:2347-2359.
    PubMed     Abstract available
    
    
    October 2024
31. ONNIS C, Virmani R, Madra A, Nardi V, et al
    Whys and Wherefores of Coronary Arterial Positive Remodeling.
    Arterioscler Thromb Vasc Biol. 2024 Oct 31. doi: 10.1161/ATVBAHA.124.321504.
    PubMed     Abstract available
    
    
    
32. WILKINSON MJ, Shapiro MD
    Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay.
    Arterioscler Thromb Vasc Biol. 2024 Oct 31. doi: 10.1161/ATVBAHA.124.319983.
    PubMed     Abstract available
    
    
    
33. ELIAS-LOPEZ D, Vedel-Krogh S, Kobylecki CJ, Wadstrom BN, et al
    Impaired Renal Function With Higher Remnant Cholesterol Related to Risk of Atherosclerotic Cardiovascular Disease: CGPS.
    Arterioscler Thromb Vasc Biol. 2024 Oct 24. doi: 10.1161/ATVBAHA.124.321387.
    PubMed     Abstract available
    
    
    
34. SU S, Chen Z, Ke Q, Kocher O, et al
    Nanoparticle-Directed Antioxidant Therapy Can Ameliorate Disease Progression in a Novel, Diet-Inducible Model of Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2024 Oct 17. doi: 10.1161/ATVBAHA.124.321030.
    PubMed     Abstract available
    
    
    
35. POTERE N, Bonaventura A, Abbate A
    Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases.
    Arterioscler Thromb Vasc Biol. 2024 Oct 10. doi: 10.1161/ATVBAHA.124.319980.
    PubMed     Abstract available
    
    
    
36. HILSER JR, Spencer NJ, Afshari K, Gilliland FD, et al
    COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type.
    Arterioscler Thromb Vasc Biol. 2024 Oct 9. doi: 10.1161/ATVBAHA.124.321001.
    PubMed     Abstract available
    
    
    September 2024
37. GASTANADUI MG, Margaroli C, Litovsky S, Richter RP, et al
    Spatial Transcriptomic Approach to Understanding Coronary Atherosclerotic Plaque Stability.
    Arterioscler Thromb Vasc Biol. 2024 Sep 5. doi: 10.1161/ATVBAHA.123.320330.
    PubMed     Abstract available
    
    
    August 2024
38. TRAVERS RJ, Stepanian A, Jaffe I
    Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors.
    Arterioscler Thromb Vasc Biol. 2024 Aug 15. doi: 10.1161/ATVBAHA.124.319864.
    PubMed     Abstract available
    
    
    
39. DEROISSART J, Binder CJ, Porsch F
    Role of Antibodies and Their Specificities in Atherosclerotic Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2024 Aug 8. doi: 10.1161/ATVBAHA.124.319843.
    PubMed     Abstract available
    
    
    
40. WU H, Wei J, Chen W, Chen L, et al
    Leisure Sedentary Behavior, Physical Activities, and Cardiovascular Disease Among Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease.
    Arterioscler Thromb Vasc Biol. 2024 Aug 1. doi: 10.1161/ATVBAHA.124.321214.
    PubMed     Abstract available
    
    
    
41. PROTTY MB, Tyrrell VJ, Allen-Redpath K, Soyama S, et al
    Thrombin Generation Is Associated With Extracellular Vesicle and Leukocyte Lipid Membranes in Atherosclerotic Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2024 Aug 1. doi: 10.1161/ATVBAHA.124.320902.
    PubMed     Abstract available
    
    
    July 2024
42. LEE J, Gilliland T, Dron J, Koyama S, et al
    Integrative Metabolomics Differentiate Coronary Artery Disease, Peripheral Artery Disease, and Venous Thromboembolism Risks.
    Arterioscler Thromb Vasc Biol. 2024 Jul 25. doi: 10.1161/ATVBAHA.124.321282.
    PubMed     Abstract available
    
    
    
43. GUNASENA M, Alles M, Wijewantha Y, Mulhern W, et al
    Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19.
    Arterioscler Thromb Vasc Biol. 2024 Jul 11. doi: 10.1161/ATVBAHA.124.321085.
    PubMed     Abstract available
    
    
    
44. ZHANG H, Kafeiti N, Masarik K, Lee S, et al
    Decoding Endothelial MPL and JAK2V617F Mutation: Insight Into Cardiovascular Dysfunction in Myeloproliferative Neoplasms.
    Arterioscler Thromb Vasc Biol. 2024 Jul 11. doi: 10.1161/ATVBAHA.124.321008.
    PubMed     Abstract available
    
    
    
45. LIU X, Yuan M, Zhao D, Zeng Q, et al
    Single-Nucleus Transcriptomic Atlas of Human Pericoronary Epicardial Adipose Tissue in Normal and Pathological Conditions.
    Arterioscler Thromb Vasc Biol. 2024;44:1628-1645.
    PubMed     Abstract available
    
    
    
46. 
    Correction to: Colchicine's Role in Cardiovascular Disease Management.
    Arterioscler Thromb Vasc Biol. 2024;44:e208.
    PubMed    
    
    
    
47. WANG X, Liu L, Zhai L, Palade P, et al
    Direct Impact of PCSK9 on SMC Senescence and Apoptosis: A New Focus in Cardiovascular Diseases.
    Arterioscler Thromb Vasc Biol. 2024;44:1491-1496.
    PubMed    
    
    
    
48. ZHAO C, Lv R, Maehara A, Wang L, et al
    Plaque Ruptures Are Related to High Plaque Stress and Strain Conditions: Direct Verification by Using In Vivo OCT Rupture Data and FSI Models.
    Arterioscler Thromb Vasc Biol. 2024;44:1617-1627.
    PubMed     Abstract available
    
    
    June 2024
49. MENCKE R, Al Ali L, de Koning MLY, Pasch A, et al
    Serum Calcification Propensity Is Increased in Myocardial Infarction and Hints at a Pathophysiological Role Independent of Classical Cardiovascular Risk Factors.
    Arterioscler Thromb Vasc Biol. 2024 Jun 20. doi: 10.1161/ATVBAHA.124.320974.
    PubMed     Abstract available
    
    
    May 2024
50. O'BRIEN JW, Case A, Kemper C, Zhao TX, et al
    Therapeutic Avenues to Modulate B-Cell Function in Patients With Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2024 May 30. doi: 10.1161/ATVBAHA.124.319844.
    PubMed     Abstract available
    
    
    
51. TRINDER M, Cermakova L, Ruel I, Baass A, et al
    Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2024 May 23. doi: 10.1161/ATVBAHA.123.320287.
    PubMed     Abstract available
    
    
    
52. BELIARD S, Saheb S, Litzler-Renault S, Vimont A, et al
    Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2024 May 2. doi: 10.1161/ATVBAHA.123.320609.
    PubMed     Abstract available
    
    
    
53. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study.
    Arterioscler Thromb Vasc Biol. 2024;44:1144-1155.
    PubMed     Abstract available
    
    
    April 2024
54. GHOUSE J, Ahlberg G, Rand SA, Olesen MS, et al
    Potential Influence of Risk Factor Control on the Association Between Lipoprotein(a) and Atherosclerotic Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2024 Apr 25. doi: 10.1161/ATVBAHA.124.320990.
    PubMed    
    
    
    
55. SOUCY A, Potts C, Kaija A, Harrington A, et al
    Effects of a Global Rab27a Null Mutation on Murine PVAT and Cardiovascular Function.
    Arterioscler Thromb Vasc Biol. 2024 Apr 25. doi: 10.1161/ATVBAHA.124.320969.
    PubMed     Abstract available
    
    
    
56. SELVARAJAN I, Kiema M, Huang RT, Li J, et al
    Coronary Artery Disease Risk Variant Dampens the Expression of CALCRL by Reducing HSF Binding to Shear Stress Responsive Enhancer in Endothelial Cells In Vitro.
    Arterioscler Thromb Vasc Biol. 2024 Apr 11. doi: 10.1161/ATVBAHA.123.318964.
    PubMed     Abstract available
    
    
    
57. TAKEDA S, Emoto T, Yamashita T, Yamamoto H, et al
    Single-Cell RNA Sequencing Reveals an Immune Landscape of CD4(+) T Cells in Coronary Culprit Plaques With Acute Coronary Syndrome in Humans.
    Arterioscler Thromb Vasc Biol. 2024 Apr 4. doi: 10.1161/ATVBAHA.123.320409.
    PubMed     Abstract available
    
    
    
58. DAUGHERTY A, Sawada H, Sheppard MB, Lu HS, et al
    Angiotensinogen as a Therapeutic Target for Cardiovascular and Metabolic Diseases.
    Arterioscler Thromb Vasc Biol. 2024 Apr 4. doi: 10.1161/ATVBAHA.124.318374.
    PubMed     Abstract available
    
    
    March 2024
59. BUCKLEY LF, Libby P
    Role of Colchicine in Cardiovascular Disease Management.
    Arterioscler Thromb Vasc Biol. 2024 Mar 21. doi: 10.1161/ATVBAHA.124.319851.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.